Comparative efficacy and safety of Chinese medicine injections as an adjunctive therapy for cervical cancer in Chinese patients: a network meta-analysis
CONCLUSIONS: The optimal recommendation depends on whether CMIs are used with radiotherapy or concurrent chemoradiotherapy. More high-quality RCTs are needed to confirm further and update the existing evidence.PMID:38334090 | PMC:PMC10860435 | DOI:10.1080/13880209.2024.2312217
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Authors: Fei Ma Qun Wang Di Zhang Zihong Wang Hui Xie Xianghong Liu Hongxing Zhang Haiyan Song Shiguang Sun Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Cervical Cancer | China Health | Databases & Libraries | Docetaxel | Drugs & Pharmacology | Gastroenterology | Science | Taxotere